🇺🇸 FDA
Patent

US 11939363

Translatable molecules and synthesis thereof

granted A61KA61K31/7115A61K38/00

Quick answer

US patent 11939363 (Translatable molecules and synthesis thereof) held by ARCTURUS THERAPEUTICS, INC. expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ARCTURUS THERAPEUTICS, INC.
Grant date
Tue Mar 26 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/7115, A61K38/00, A61K38/1709, A61K38/1816